CD4 and neoplasm: Collectively, Sora promotes the differentiation but not the proliferation of Treg cells, leading to the expansion of tumor-infiltrating immunosuppressive Treg cells by modulating the VEGFR/ Akt/Foxo1 pathway in CD4+ T cells, thus conferring Sora resistance.